Evaluation of TNF superfamily molecules release by neutrophils and b leukemic cells of patients with chronic B - cell lymphocytic leukemia

Neoplasma

Volumn 58, Issue 1, 2011, Pages 45-50

  Sawicka Powierza, J ^a   Jablonska, E ^a   Kloczko, J ^a   Piszcz, J ^a   Garley, M ^a   Ratajczk Wrona, W ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

A proliferation inducing ligand (APRIL); B cell activating factor (BAFF); B cell chronic lymphocytic leukemia (B CLL); TNF related apoptosis inducing ligand (TRAIL); Tumor necrosis factor (TNF)

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TNFSF10 PROTEIN, HUMAN; TNFSF13 PROTEIN, HUMAN;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; B CELL LEUKEMIA; CELL ISOLATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; MOLECULE; NEUTROPHIL; PROTEIN EXPRESSION; PROTEIN SECRETION; SERUM; SUPERNATANT; WESTERN BLOTTING; B LYMPHOCYTE; BLOOD; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MIDDLE AGED; NEUTROPHILS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 79961117916     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_01_45     Document Type: Article

References (22)

1. NG LG, MACKAY CR, MACKAY F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 2005; 42: 763-772. doi:10.1016/j.molimm.2004.06.041
2. EHRLICH S, INFANTE-DUARTE C, SEEGER B, ZIPP F. Regulation of soluble and surface-bound TRAIL in human T cells, B cells and monocytes. Cytokine 2003; 24: 244-253. doi:10.1016/S1043-4666(03)00094-2.
3. MACFARLANE M. TRAIL-induced signalling and apoptosis. Toxicol Lett 2003; 139: 89-97. doi:10.1016/S0378-4274(02)00422-8
4. HAIAT S, BILLARD C, QUINEY C, AJCHENBAUMCYM-BALISTA F, KOLB JP. Role of BAFF and APRIL in human B-cell chronic lymhocytic leukaemia. Immunology 2006; 118: 281-292. doi:10.1111/j.1365-2567.2006.02377.x
5. MACKAY F, TANGYE SG. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr Opin Pharmacol 2004; 4: 347-354. doi:10.1016/j.coph.2004.02.009
6. OLSSON A, DIAZ T, AGUILAR-SANTELISES M, OSTERBORG A, CELSING F et al. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D. Leukemia 2001; 15: 1868-1877.
7. GUAN ZB, SHUI Y, ZHANG SQ. Two related ligands of the TNF family, BAFF and APRIL, in rabbit: molecular cloning, 3D modeling, and tissue distribution. Cytokine 2007; 39: 192-200. doi:10.1016/j.cyto.2007.07.190
8. HENDRIKS J, PLANELLES L, DE JONG-ODDING J, HARDENBERG G, PALS ST et al. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 2005; 12: 637-648. doi:10.1038/sj.cdd.4401647.
9. GRIFFITH TS, LYNCH DH. TRAIL: a molecule with multiple receptors and control mechanisms. Curr Opin Immunol 1998; 10: 559-563. doi:10.1016/S0952-7915(98)80224-0
10. JABLONSKA E, KIERSNOWSKA-ROGOWSKA B, ALEKSANDROWICZ-BUKIN M, ROGOWSKI F, SAWICKA-POWIERZA J. TRAIL receptors in the serum of patients with B-cell chronic lymphocytic leukemia. Neoplasma 2008; 55: 51-54.
11. KOGA Y, MATSUZAKI A, SUMINOE A, HATTORI H, HARA T. Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils. Cancer Res 2004; 64: 1037-1043. doi:10.1158/0008-5472.CAN-03-1808
12. SCAPINI P, BAZZONI F, CASSATELLA MA. Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BlyS) expression in human neutrophils. Immunol Lett 2008; 116: 1-6.
13. MHAWECH-FAUCEGLIA P, KAYA G, SAUTER G, MCKEE T, DONZE O et al. The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol 2006; 80: 697-704. doi:10.1189/jlb.1105655
14. BOJARSKA-JUNAK A, HUS I, CHOCHOLSKA S, WASIKSZCZEPANEK E, SIEKLUCKA M et al. BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features. Leuk Res 2009; 33: 1319-1327. doi:10.1016/j.leukres.2009.03.030
15. ENDO T, NISHIO M, ENZLER T, COTTAM HB, FUKUDA T et al. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 2007; 109: 703-710. doi:10.1182/blood-2006-06-027755
16. PLANELLES L, CASTILLO-GUTIERREZ S, MEDEMA JP. MORALES-LUQUE A, MERLE-BERAL H et al. APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival. Haematologica 2007; 92: 1284-1285. doi:10.3324/haematol.10317
17. RAI KR, SAWITSKY A, CRONKITE EP, CHANANA AD, LEVY RN et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219-234.
18. HALLEK M, CHESON BD, CATOVSKY D, CALIGARIS-CAPPIO F, DIGHIERO G et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111: 5446-5456. Erratum in: Blood 2008; 112: 5259.
19. DJURDJEVIC P, ZELEN I, RISTIC P, BASKIC D, POPOVIC S et al. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro. Arch Med. Res 2009; 40: 357-363. doi:10.1016/j.arcmed.2009.05.007
20. CASSATELLA MA. On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils. J Leukoc Biol 2006; 79: 1140-1149. doi:10.1189/jlb.1005558
21. di CARLO E, FORNI G, LOLLINI P, COLOMBO MP, MODESTI A et al. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001; 97: 339-345. doi:10.1182/blood.V97.2.339
22. PHILLIPS TA, NI J, HUNT JS. Cell-specyfic expression of B lymphocyte (APRIL, BlyS)-and Th2(CD30L/CD153)-promoting tumor necrosis factor superfamily ligands in human placentas. J Leukoc Biol 2003; 74: 81-87. doi:10.1189/ jlb.0103033.